{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:53:26Z","timestamp":1782489206120,"version":"3.54.5"},"reference-count":68,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"unspecified","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-169055"],"award-info":[{"award-number":["PJT-169055"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,4,10]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Equity, diversity and inclusion (EDI), patient engagement and shared decision-making are important considerations throughout clinical trials, including the research ethics review stage. Meaningfully integrating these considerations can enhance the relevance and generalisability of trial results and reduce participation barriers among equity-deserving populations. Presently, it is unclear to what extent such guidance is provided at the ethics application stage for clinical trials. This study aimed to report the degree of guidance on EDI, patient engagement and shared decision-making in clinical trial research ethics documents.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>This was an embedded mixed methods study conducted in collaboration with Clinical Trials Ontario.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>This study analysed research ethics board (REB) forms and templates from 17 institutions across seven provinces in Canada.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants and methods<\/jats:title>\n                    <jats:p>15 REB application forms, 9 protocol templates and 17 informed consent document (ICD) templates were assessed for guidance related to EDI, patient engagement and shared decision-making. The Place of residence, Race, ethnicity, culture and language, Occupation, Gender and sex, Religion, Education, Socio-economic status, Social capital (PROGRESS)-Plus framework, International Association for Public Participation Spectrum of Public Participation, Patient-Oriented Research Level of Engagement Tool, Indigenous Research Level of Engagement Tool and shared decision-making standards guided our coding. We engaged with patients and persons with lived experience to inform interpretation, reporting and dissemination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>EDI guidance from 15 ethics application forms and 9 protocol templates predominantly covered the \u2018Race, ethnicity, culture, language\u2019 (n=14; 93.3%), \u2018Age\u2019 (n=13; 86.7%) and \u2018Gender and sex\u2019 (n=12; 80%) categories of PROGRESS-Plus but lacked nuance on diverse gender identities (n=1; 6.7%). Patient engagement guidance mostly covered the \u2018inform\u2019 level (n=7; 46.7%) and applying \u2018knowledge in practice\u2019 with non-Indigenous (n=7; 46.7%) or Indigenous communities (n=13; 86.7%). All 17 (100%) ICD templates included guidance on information about options, disclosures, key elements, ethical issues and study design. No guidance was available on time-dependent relationships, empowering patients and communities in co-leading trials or providing structured guidance in making trial participation decisions (all n=0; 0%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We provided a comprehensive view of EDI, patient engagement and shared decision-making guidance in trial ethics applications in Canada. REB guidance may be strengthened in several areas to support the inclusion of equity-deserving populations in trials, meaningful engagement with patients and Indigenous communities and evidence-informed, values-aligned decisions about trial participation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-113057","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T13:25:27Z","timestamp":1777987527000},"page":"e113057","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Patient engagement, shared decision-making and equity, diversity and inclusion considerations in research ethics board application forms and templates in Canada: a mixed methods study"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6100-7359","authenticated-orcid":false,"given":"Tamara L","family":"Morgan","sequence":"first","affiliation":[{"name":"Methodological and Implementation Research Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Carroll","sequence":"additional","affiliation":[{"name":"Methodological and Implementation Research Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena","family":"Mosa","sequence":"additional","affiliation":[{"name":"Methodological and Implementation Research Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Hudek","sequence":"additional","affiliation":[{"name":"Methodological and Implementation Research Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn P","family":"Richards","sequence":"additional","affiliation":[{"name":"Clinical Trials Ontario, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Marlin","sequence":"additional","affiliation":[{"name":"Clinical Trials Ontario, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Meeking","sequence":"additional","affiliation":[{"name":"Queering Cancer, Centreville, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7933-4593","authenticated-orcid":false,"given":"Cole","family":"Etherington","sequence":"additional","affiliation":[{"name":"Methodological and Implementation Research Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Presseau","sequence":"additional","affiliation":[{"name":"Methodological and Implementation Research Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"University of Ottawa School of Epidemiology and Public Health, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie C","family":"Brehaut","sequence":"additional","affiliation":[{"name":"Methodological and Implementation Research Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"University of Ottawa School of Epidemiology and Public Health, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"2026062608313265000_16.5.e113057.1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.conctc.2016.01.002","article-title":"Factors affecting patient participation in clinical trials in Ireland: A narrative review","volume":"3","author":"Walsh","year":"2016","journal-title":"Contemp Clin Trials Commun"},{"key":"2026062608313265000_16.5.e113057.2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djy221"},{"key":"2026062608313265000_16.5.e113057.3","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-07711-1"},{"key":"2026062608313265000_16.5.e113057.4","doi-asserted-by":"crossref","unstructured":"Bibbins-Domingo K , Ch HA . n.d. 2 Why Diverse Representation in Clinical Research Matters and the Current State of Representationwithin the Clinical Research Ecosystem. 2022:23\u201346. doi:10.17226\/26479","DOI":"10.17226\/26479"},{"key":"2026062608313265000_16.5.e113057.5","first-page":"1","article-title":"Community engagement and clinical trial diversity: Navigating barriers and co-designing solutions\u2014A report from the \u201cHealth Equity through Diversity","volume":"18","author":"Reopell","year":"2023","journal-title":"Seminar Series PLoS ONE"},{"key":"2026062608313265000_16.5.e113057.6","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-14-42","article-title":"Reaching the hard-to-reach: a systematic review of strategies for improving health and medical research with socially disadvantaged groups","volume":"14","author":"Bonevski","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"2026062608313265000_16.5.e113057.7","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/cncr.33399","article-title":"Use of a clinical trial screening tool to enhance patient accrual","volume":"127","author":"St. Germain","year":"2021","journal-title":"Cancer"},{"key":"2026062608313265000_16.5.e113057.8","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33905"},{"key":"2026062608313265000_16.5.e113057.9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-021-00316-8","article-title":"Improving diversity in medical research","volume":"7","author":"Sharma","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2026062608313265000_16.5.e113057.10","first-page":"1","article-title":"Increasing Inclusiveness of Patient-Centric Clinical Evidence Generation in Oncology: Real-World Data and Clinical Trials","volume":"42","author":"Benbow","year":"2022","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2026062608313265000_16.5.e113057.11","first-page":"1","article-title":"Strategies to Advance Equity in Cancer Clinical Trials","volume":"42","author":"Guerra","year":"2022","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2026062608313265000_16.5.e113057.12","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6963-14-89","article-title":"Patient engagement in research: a systematic review","volume":"14","author":"Domecq","year":"2014","journal-title":"BMC Health Serv Res"},{"key":"2026062608313265000_16.5.e113057.13","first-page":"27","article-title":"Equity, diversity, inclusion, and social justice in CanMEDS 2025","volume":"14","author":"Barnabe","year":"2023","journal-title":"Can Med Educ J"},{"key":"2026062608313265000_16.5.e113057.14","doi-asserted-by":"crossref","first-page":"107092","DOI":"10.1016\/j.cct.2023.107092","article-title":"Diversity, equity, and inclusion in clinical trials: A practical guide from the perspective of a trial sponsor","volume":"126","author":"Versavel","year":"2023","journal-title":"Contemp Clin Trials"},{"key":"2026062608313265000_16.5.e113057.15","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.2217\/fon-2021-0556","article-title":"Pragmatic patient engagement in designing pragmatic oncology clinical trials","volume":"17","author":"Davies-Teye","year":"2021","journal-title":"Future Oncol"},{"key":"2026062608313265000_16.5.e113057.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2005.06.010"},{"key":"2026062608313265000_16.5.e113057.17","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-021-05257-x","article-title":"Using behavioral theory and shared decision-making to understand clinical trial recruitment: interviews with trial recruiters","volume":"22","author":"Brehaut","year":"2021","journal-title":"Trials"},{"key":"2026062608313265000_16.5.e113057.18","article-title":"Decision aids for people facing health treatment or screening decisions","volume":"4","author":"Stacey","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2026062608313265000_16.5.e113057.19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-058380","article-title":"Factors influencing decisions about whether to participate in health research by people of diverse ethnic and cultural backgrounds: a realist review","volume":"12","author":"Hoverd","year":"2022","journal-title":"BMJ Open"},{"key":"2026062608313265000_16.5.e113057.20","unstructured":"Secretariat on Responsible Conduct of Research . Tri-council policy statement: ethical conduct for research involving humans. 2022. Available: https:\/\/ethics.gc.ca\/eng\/documents\/tcps2-2022-en.pdf [Accessed 4 Jun 2025]."},{"key":"2026062608313265000_16.5.e113057.21","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1089\/heq.2018.0020","article-title":"Importance of Shared Decision-Making for Vulnerable Populations: Examples from Postmastectomy Breast Reconstruction","volume":"2","author":"Grabinski","year":"2018","journal-title":"Health Equity"},{"key":"2026062608313265000_16.5.e113057.22","unstructured":"Government of Canada . Research Ethics Board: About the REB, 2024. Available: https:\/\/www.canada.ca\/en\/health-canada\/services\/science-research\/science-advice-decision-making\/research-ethics-board\/about-us.html [Accessed 18 Jan 2024]."},{"key":"2026062608313265000_16.5.e113057.23","unstructured":"Wilkinson A , Slack C , Crews C , et al . How can research ethics committees help to strengthen stakeholder engagement in health research in South Africa? An evaluation of REC documents. South Afr J Bioeth Law 2021;14."},{"key":"2026062608313265000_16.5.e113057.24","first-page":"313","article-title":"Ethics application protocols for multicentre clinical studies in Canada: A paediatric rheumatology experience","volume":"17","author":"Matheson","year":"2012","journal-title":"Paediatr Child Health"},{"key":"2026062608313265000_16.5.e113057.25","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.1200\/JCO.2021.39.15_suppl.6518","article-title":"National Cancer Institute (NCI) implementation of the American Society of Clinical Oncology (ASCO) and Friends of Cancer Research (Friends) broadening clinical trials eligibility criteria","volume":"39","author":"Denicoff","year":"2021","journal-title":"JCO"},{"key":"2026062608313265000_16.5.e113057.26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-029024","article-title":"Innovative approaches to investigator-initiated, multicentre paediatric clinical trials in Canada","volume":"9","author":"Kelly","year":"2019","journal-title":"BMJ Open"},{"key":"2026062608313265000_16.5.e113057.27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.18865\/ed.29.S1.97","article-title":"Partnerships to Improve Shared Decision Making for Patients with Hypertension - Health Equity Implications","volume":"29","author":"Langford","year":"2019","journal-title":"Ethn Dis"},{"key":"2026062608313265000_16.5.e113057.28","doi-asserted-by":"publisher","DOI":"10.1037\/amp0000151"},{"key":"2026062608313265000_16.5.e113057.29","doi-asserted-by":"crossref","unstructured":"Tamminen KA , Poucher ZA . Research philosophies. In: Hackfort D , Schinke R , eds. The routledge international encyclopedia of sport and exercise psychology. 2020.","DOI":"10.4324\/9781315187259-39"},{"key":"2026062608313265000_16.5.e113057.30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/1750984X.2019.1656276","article-title":"Thinking through and designing qualitative research studies: a focused mapping review of 30 years of qualitative research in sport psychology","volume":"13","author":"Poucher","year":"2020","journal-title":"Int Rev Sport Exerc Psychol"},{"key":"2026062608313265000_16.5.e113057.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.08.005"},{"key":"2026062608313265000_16.5.e113057.32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.12927\/hcq.2020.26141","article-title":"The creation of a tool to measure engagement in patient-oriented research","volume":"23","author":"Keller","year":"2020","journal-title":"Healthc Q"},{"key":"2026062608313265000_16.5.e113057.33","unstructured":"International Association for Public Participation . IAP2 Spectrum Evolution, Available: https:\/\/www.iap2.org\/page\/SpectrumEvolution [Accessed 18 Aug 2025]."},{"key":"2026062608313265000_16.5.e113057.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.03.028"},{"key":"2026062608313265000_16.5.e113057.35","doi-asserted-by":"crossref","first-page":"104905","DOI":"10.1016\/j.healthpol.2023.104905","article-title":"Community-based participatory research to engage disadvantaged communities: Levels of engagement reached and how to increase it. A systematic review","volume":"137","author":"Riccardi","year":"2023","journal-title":"Health Policy"},{"key":"2026062608313265000_16.5.e113057.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2012.01.004"},{"key":"2026062608313265000_16.5.e113057.37","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.jclinepi.2015.03.002","article-title":"Elements of informed consent and decision quality were poorly correlated in informed consent documents","volume":"68","author":"Brehaut","year":"2015","journal-title":"J Clin Epidemiol"},{"key":"2026062608313265000_16.5.e113057.38","unstructured":"Clinical Trials Ontario . The College of Lived Experience, 2025. Available: https:\/\/ctontario.ca\/programs\/college-of-lived-experience\/ [Accessed 18 Aug 2025]."},{"key":"2026062608313265000_16.5.e113057.39","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.j3453","article-title":"GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research","volume":"358","author":"Staniszewska","year":"2017","journal-title":"BMJ"},{"key":"2026062608313265000_16.5.e113057.40","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"key":"2026062608313265000_16.5.e113057.41","doi-asserted-by":"crossref","DOI":"10.1038\/s43856-024-00586-9","article-title":"The influence of socioeconomic status on individual attitudes and experience with clinical trials","volume":"4","author":"Kim","year":"2024","journal-title":"Commun Med (Lond)"},{"key":"2026062608313265000_16.5.e113057.42","doi-asserted-by":"crossref","DOI":"10.1186\/s12910-023-00987-w","article-title":"Equality, diversity, and inclusion in oncology clinical trials: an audit of essential documents and data collection against INCLUDE under-served groups in a UK academic trial setting","volume":"24","author":"Patel","year":"2023","journal-title":"BMC Med Ethics"},{"key":"2026062608313265000_16.5.e113057.43","unstructured":"Employment and Social Development Canada . About an accessible Canada. 2025. Available: https:\/\/www.canada.ca\/en\/employment-social-development\/programs\/accessible-canada.html [Accessed 5 Jun 2025]."},{"key":"2026062608313265000_16.5.e113057.44","unstructured":"The Act (AODA) . Accessibility for ontarians with disabilities act. 2005. Available: https:\/\/www.aoda.ca\/the-act\/ [Accessed 5 Jun 2025]."},{"key":"2026062608313265000_16.5.e113057.45","unstructured":"Employment and Social Development Canada . Canada\u2019s disability inclusion action plan. 2022."},{"key":"2026062608313265000_16.5.e113057.46","doi-asserted-by":"crossref","first-page":"100946","DOI":"10.1016\/j.jemep.2023.100946","article-title":"Language inclusivity in health research: An institutional current state quality assessment","volume":"31","author":"An","year":"2023","journal-title":"Ethics Med Public Health"},{"key":"2026062608313265000_16.5.e113057.47","unstructured":"Canadian Institutes of Health Research . Sex and gender training modules. 2025. Available: https:\/\/www.cihr-irsc-igh-isfh.ca\/ [Accessed 5 Jun 2025]."},{"key":"2026062608313265000_16.5.e113057.48","doi-asserted-by":"publisher","DOI":"10.1177\/1757975914528961"},{"key":"2026062608313265000_16.5.e113057.49","unstructured":"Healthcare Excellence Canada . Healthcare excellence Canada\u2019s patient engagement framework. 2023. Available: https:\/\/www.healthcareexcellence.ca\/en\/resources\/healthcare-excellence-canada-s-patient-engagement-framework\/ [Accessed 2 Jun 2025]."},{"key":"2026062608313265000_16.5.e113057.50","doi-asserted-by":"crossref","DOI":"10.1017\/cts.2023.16","article-title":"Community engagement strategies to promote recruitment and participation in clinical research among rural communities: A narrative review","volume":"7","author":"Brockman","year":"2023","journal-title":"J Clin Transl Sci"},{"key":"2026062608313265000_16.5.e113057.51","unstructured":"Saskatchewan Centre for Patient-Oriented Research . Patient-oriented research level of engagement tool. 2021. Available: https:\/\/static1.squarespace.com\/static\/5c869fd0e666695abe893b3b\/t\/61b0f04d878a731b75039cdf\/1638985805316\/PORLET+2021+12+08.pdf [Accessed 30 May 2025]."},{"key":"2026062608313265000_16.5.e113057.52","unstructured":"Saskatchewan Centre for Patient-Oriented Research . Indigenous research level of engagement tool. 2022. Available: https:\/\/static1.squarespace.com\/static\/5c869fd0e666695abe893b3b\/t\/62574578aa00f85ba7968c79\/1649886584742\/IRLET+2022.pdf [Accessed 30 May 2025]."},{"key":"2026062608313265000_16.5.e113057.53","unstructured":"First Nations Information Governance Centre . The first nations principles of OCAP\u00ae. 1998. Available: https:\/\/fnigc.ca\/ocap-training\/ [Accessed 5 Jun 2025]."},{"key":"2026062608313265000_16.5.e113057.54","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25172","article-title":"Strengthening stakeholder engagement through ethics review in biomedical HIV prevention trials: opportunities and complexities","volume":"21 Suppl 7","author":"Slack","year":"2018","journal-title":"J Int AIDS Soc"},{"key":"2026062608313265000_16.5.e113057.55","unstructured":"National Health Service Health Research Authority . Helping to ensure public involvement informs ethical review, 2023. Available: https:\/\/www.hra.nhs.uk\/approvals-amendments\/what-approvals-do-i-need\/research-ethics-committee-review\/fast-track-research-ethics-review-pilot\/helping-ensure-public-involvement-informs-ethical-review\/ [Accessed 19 Aug 2025]."},{"key":"2026062608313265000_16.5.e113057.56","unstructured":"Canadian Institutes of Health Research . Ethics guidance for developing partnerships with patients and researchers. 2020. Available: https:\/\/cihr-irsc.gc.ca\/e\/51910.html [Accessed 29 Oct 2024]."},{"key":"2026062608313265000_16.5.e113057.57","first-page":"487","article-title":"Promoting inclusion in clinical trials: A rapid review of the literature and recommendations for action","volume":"15","author":"Chopde","year":"2023","journal-title":"Int J Pharm Clin Res"},{"key":"2026062608313265000_16.5.e113057.58","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1353\/hpu.2023.0026","article-title":"Understanding Hispanic\/Latino Participation in Clinical Trials and Observational Studies, and Strategies to Increase Participation: A Targeted Literature Review","volume":"34","author":"Dreyfus","year":"2023","journal-title":"J Health Care Poor Underserved"},{"key":"2026062608313265000_16.5.e113057.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2018.10.048"},{"key":"2026062608313265000_16.5.e113057.60","unstructured":"Employment and Social Development Canada . Consulting persons with disabilities: Annex: Understanding disabilities, 2022. Available: https:\/\/www.canada.ca\/en\/employment-social-development\/programs\/accessible-canada-regulations-guidance\/consultation\/key-concepts.html#h2.5 [Accessed 5 Jun 2025]."},{"key":"2026062608313265000_16.5.e113057.61","doi-asserted-by":"crossref","DOI":"10.1017\/cts.2022.510","article-title":"Barriers to and solutions for representative inclusion across the lifespan and in life course research: The need for structural competency highlighted by the COVID-19 pandemic","volume":"7","author":"LeCroy","year":"2023","journal-title":"J Clin Transl Sci"},{"key":"2026062608313265000_16.5.e113057.62","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/13645579.2024.2357558","article-title":"Decolonial research methodology: an assessment of the challenge to established practice","volume":"28","author":"Denscombe","year":"2025","journal-title":"Int J Soc Res Methodol"},{"key":"2026062608313265000_16.5.e113057.63","unstructured":"World Health Organization . Standards and operational guidance for ethics review of health-related research with human participants. 2011."},{"key":"2026062608313265000_16.5.e113057.64","unstructured":"Council for International Organizations of Medical Sciences (CIOMS) . International ethical guidelines for health-related research involving humans. 2016."},{"key":"2026062608313265000_16.5.e113057.65","article-title":"Decision aids for people considering taking part in clinical trials","volume":"2015","author":"Gillies","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2026062608313265000_16.5.e113057.66","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-019-3489-y","article-title":"Development and evaluation of decision aids for people considering taking part in a clinical trial: a conceptual framework","volume":"20","author":"Gillies","year":"2019","journal-title":"Trials"},{"key":"2026062608313265000_16.5.e113057.67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2023.02.013"},{"key":"2026062608313265000_16.5.e113057.68","doi-asserted-by":"crossref","DOI":"10.1016\/j.puhip.2023.100430","article-title":"Equity-focused evidence synthesis - A need to optimise our approach","volume":"6","author":"McCann","year":"2023","journal-title":"Public Health Pract (Oxf)"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-113057","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:41:11Z","timestamp":1782488471000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-113057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":68,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,5]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/bmjopen-2025-113057"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-113057","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}